Evaluation of Comparative Efficacy of Chitraka Haritaki Avaleha Versus Chyavanprash Avaleha In The Management of Recurrent Respiratory Illness In Children A Randomized Control Trial
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
ABSRACT
newlineAyurveda is combination of philosophy and medicine which holds good principles of nature, and systematically divided into eight clinical branches. Kaumarbritya is one among these eight branches contains the principles and practices regarding the varied aspects of a child care, starting from the newborn care. Respiratory disease is the major cause of mortality and morbidity worldwide, with infants and young children especially susceptible. Among several respiratory diseases common cold sore throat , cough are the most common illnesses followed by any type of respiratory illness, its harmful to child s health and disturb routine as well as school performance. To evaluate comparative efficacy of Chitraka Haritaki Avaleha and Chyavanprash Avaleha was taken in Recurrent Respiratory Illnesses In Children. These Ayurvedic drugs also have immunomodulatory action especially on respiratory system. Hence study planned to observe the therapeutic effects of Chitraka Haritaki Avaleha, to develop a rational approach, and to find out therapeutic and safe countermeasures. Aim: To Evaluate The Comparative Efficacy Of Chitraka Haritaki Avaleha Versus Chyavanprash Avaleha In The Management Of Recurrent Respiratory Illness In Children Through Non Inferiority Trial. Objectives: 1. To Study the efficacy of Chitraka Haritaki Avaleha in the management of Recurrent Respiratory illness in Children. 2. To study the efficacy of Chyavanaprash Avaleha in the management of Recurrent Respiratory illnesses in Children. 3. To compare the efficacy of Chitraka Haritaki Avaleha and Chyavanaprash Avaleha in the management of Recurrent Respiratory illness in Children. Methodology: Randomized active controlled single blind non inferiority trial on 66 patients of age 2 to 6 years suffering from Recurrent Respiratory Illness, divided in to two groups(33 in each) Group A Control group was treated with Chyavanprash Avaleha for 30 days and Group B Trial group treated with Chitraka Haritaki Avaleha for 30 days. Assessment was recorded on baseline, 5th